Respiratory Pharmacology

Kredit

Handouts

Sprecher

Paul Langlois, APN, PhD, CCRN, CCNS Related seminars and products

---

Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.

Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.

His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.  

 

Speaker Disclosures:
Financial: Paul Langlois has employment relationships with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Paul Langlois is a member of the American Nurses Association and the American Association of Critical Care Nurses.

Zusätzliche Informationen

Programm-Informationen

Der Zugang zu diesem Produkt läuft nie ab.

Für eine detailliertere Übersicht, die bei Bedarf auch Zeiten oder Zeiträume enthält, wenden Sie sich bitte an cepesi@pesi.com  

Ziele

1. Determine the best medications to use during acute asthma attack. 
2. Manage the current recommended medications for the COVID-19 patient both out- and in-patient. 
3. Formulate a medication regimen for a tuberculosis patient, both newly diagnosed and with drug-resistant tuberculosis. 
4. Devise the treatment protocol for a patient with pulmonary hypertension. 
5. Plan for optimal antibiotic selection for the patient with bacterial pneumonia. 

Gliederung

Asthma – Not Just Bronchodilators Anymore 

• How is asthma diagnosed? 
• Global Initiative for Asthma (GINA) medication options 
• Role of corticosteroids in asthma treatment 
• Short acting beta agonists (SABA), long-acting beta agonists (LABA) - the difference and monitoring parameters 
• Muscarinic antagonists, leukotriene modifiers and phosphodiesterase inhibitors - must know indications and contraindications  
• Monoclonal antibodies for asthma relief 

Chronic Obstructive Pulmonary Disease (COPD) – Long Term Pharmacologic Therapies 

• COPD causes, symptoms and diagnostic tests 
• Non-pharmacologic treatments 
• SABA and LABA - when and how much 
• Inhaled corticosteroids alone or in combination with bronchodilators 
• Vaccines are a must – which ones and at what age to administer 

SARS-CoV2, COVID-19 

• Laboratory parameters for SARS-CoV2 
• How effective are all those COVID-19 vaccines 
• Which antiviral medications are FDA approved and which are still in clinical trials? 
• Dexamethasone is effective - but only in certain patient populations 

Tuberculosis (TB): Still Prevalent and Highly Contagious 

• What is Mycobacterium tuberculosis and how is it detected? 
• First line medications for drug susceptible TB (doses, how often & how long to take) 
• Multi-drug resistant TB treatments 

Pulmonary Hypertension 

• Diagnosis of pulmonary hypertension  
• 12-lead ECG results in a patient with pulmonary hypertension 
• Select between calcium channel blockers, phosphodiesterase inhibitors, endothelin receptor antagonizes and prostacyclin agonists 

Pneumonia 

• Community acquired treatment options 
• Antibiotic options based on patient history 
• Hospital acquired pharmacology 
• How to treat methicillin resistant staphylococcus aureus

Zielpublikum

• Krankenschwestern
• Praktische Krankenschwestern und -pfleger
• Pharmacists
• Ärzte
• Medizinische Fachangestellte
• Respiratory Therapists